|
Research Management and Support
|
RMS2011 [E]
|
$335,240,650
|
$84,837
|
N/A
|
National Cancer Institute
|
|
TAS::75 0849::TAS INCREMENTAL FUNDING
|
N01CO800001-038
|
$221,493,424
|
$52,218
|
HEIMBROOK, DAVID
|
SAIC-FREDERICK, INC.
|
|
Cancer Center Support Grant
|
5P30CA008748-46
|
$13,185,550
|
$131,856
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Abramson Cancer Center Support Grant
|
2P30CA016520-35
|
$7,696,742
|
$76,967
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Regional Oncology Research Center
|
3P30CA006973-48S3
|
$6,995,274
|
$69,953
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S3
|
$5,694,947
|
$56,949
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-37
|
$5,470,597
|
$54,706
|
DIASIO, ROBERT
|
MAYO CLINIC
|
|
Cancer Center Support Grant
|
5P30CA047904-23
|
$5,139,549
|
$102,791
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,801,787
|
$240,089
|
Fojo, Antonio
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
2P30CA016058-35
|
$4,582,303
|
$366,584
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-38
|
$4,555,705
|
$91,114
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Cancer Center Support Grant
|
3P30CA046934-23S4
|
$3,995,527
|
$79,911
|
Theodorescu, Dan
|
UNIVERSITY OF COLORADO DENVER
|
|
Core Support for Cancer Center
|
5P30CA013330-39
|
$3,725,702
|
$74,514
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-05
|
$2,934,758
|
$29,348
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Genetic and Signaling Pathways in Epithelial Thyroid Cancer
|
5P01CA124570-04
|
$2,247,656
|
$2,247,656
|
RINGEL, MATTHEW
|
OHIO STATE UNIVERSITY
|
|
Human RecQ helicases in biology and oncology
|
5P01CA077852-13
|
$1,442,050
|
$216,308
|
MONNAT, RAYMOND
|
UNIVERSITY OF WASHINGTON
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,178,242
|
$58,912
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$797,394
|
$39,870
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Gene expression and regulation in endocrine cancers
|
ZIA BC 011275
|
$736,084
|
$368,042
|
Kebebew, Electron
|
CCR (NCI)
|
|
Cancer Mortality among Military Participants at U.S. Nuclear Weapons Tests
|
5U01CA137026-02
|
$722,003
|
$72,200
|
BOICE, JOHN
|
VANDERBILT UNIVERSITY
|
|
molecular analysis of medullary thyroid carcinoma tissues
|
ZIA BC 011388
|
$687,309
|
$687,309
|
Wells, Samuel
|
CCR (NCI)
|
|
Cancer and Other Mortality Risks in a Cohort of U.S. Radiologic Technologists
|
ZIA CP010133-04180
|
$653,735
|
$98,060
|
Linet, Martha
|
DCEG (NCI)
|
|
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
|
ZIA BC 011337
|
$650,503
|
$195,151
|
Yang, James
|
CCR (NCI)
|
|
Shanghai prospective cohort study of occupational exposures and cancer risk among
|
ZIA CP010123-02342
|
$595,200
|
$29,760
|
Chow, Wong-Ho
|
DCEG (NCI)
|
|
Therapeutic targets and novel anticancer agents for endocrine cancers
|
ZIA BC 011286
|
$588,867
|
$294,434
|
Kebebew, Electron
|
CCR (NCI)
|
|
Chornobyl Thyroid Study (Ukraine)
|
ZIA CP010132-04173
|
$517,025
|
$517,025
|
Mabuchi, Kiyohiko
|
DCEG (NCI)
|
|
Preclinical Mouse Model of Thyroid Carcinogenesis
|
ZIA BC 011191
|
$511,222
|
$408,978
|
Cheng, Sheue-yann
|
CCR (NCI)
|
|
Oncogenic Events in Thyroid Neoplasia
|
5R01CA072597-15
|
$450,546
|
$450,546
|
FAGIN, JAMES
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Molecular and Histopathologic Clues to the Understanding of Thyroid Cancer Incide
|
ZIA CP010222-10490
|
$422,317
|
$422,317
|
Sigurdson, Alice
|
DCEG (NCI)
|
|
Thyroid Stem/Progenitor Cells
|
ZIA BC 005522
|
$398,891
|
$398,891
|
Kimura, Shioko
|
CCR (NCI)
|
|
Tip60 in p38 and PRAK Mediated Oncogene-Induced Senescence and Tumor Suppression
|
4R01CA131231-03
|
$382,221
|
$126,133
|
SUN, PEIQING
|
SCRIPPS RESEARCH INSTITUTE
|
|
Targeting BRAF and MEK in tumors with BRAF and RAS mutations.
|
5R01CA127240-04
|
$376,384
|
$94,096
|
SOLIT, DAVID
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Radiation-induced Thyroid Cancer
|
5R01CA136685-03
|
$371,728
|
$371,728
|
WEIER, HEINZ-ULRICH
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
|
Chornobyl Thyroid Study (Belarus)
|
ZIA CP010132-04019
|
$370,574
|
$370,573
|
Mabuchi, Kiyohiko
|
DCEG (NCI)
|
|
RCAN1 in Thyroid Cancer Progression
|
1R01CA152066-01A1
|
$350,983
|
$350,983
|
RINGEL, MATTHEW
|
OHIO STATE UNIVERSITY
|
|
Adrenocortical Cancer and Thyroid Carcinomas: Models with Unique Properties
|
ZIA BC 010626
|
$347,117
|
$173,559
|
Fojo, Antonio
|
CCR (NCI)
|
|
PHAH and thyroid cancer
|
ZIA CP010125-10473
|
$341,582
|
$341,581
|
Ward, Mary
|
DCEG (NCI)
|
|
Genetic analysis of the P13K/Akt pathway in thyroid benign and malignant disease
|
5R01CA128943-03
|
$334,117
|
$334,117
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Intervention models for thyroid proliferative disease using a bioactive food comp
|
4R01CA131946-03
|
$332,786
|
$332,786
|
TIWARI, RAJ
|
NEW YORK MEDICAL COLLEGE
|
|
Molecular Events in the PI3K/Akt Pathway in Thyroid Cancer
|
5R01CA134225-03
|
$327,257
|
$327,257
|
XING, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Rap1Gap and Tumor Progression
|
5R01CA127986-03
|
$322,040
|
$322,040
|
MEINKOTH, JUDY
|
UNIVERSITY OF PENNSYLVANIA
|
|
The Role of BRAF Mutation in Thyroid Cancer Invasion
|
1R01CA149738-01A1
|
$320,961
|
$320,961
|
Parangi, Sareh
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Pax8-PPARgamma regulation of transcription and metabolism in thyroid cancer
|
5R01CA151842-02
|
$318,219
|
$318,219
|
KOENIG, RONALD
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Cancer immunotherapy with a live recombinant vaccine
|
5R01CA069632-13
|
$317,115
|
$317,115
|
PATERSON, YVONNE
|
UNIVERSITY OF PENNSYLVANIA
|
|
RhoB in cancer pathogenesis and as a target in combinatorial therapy
|
5R01CA136665-02
|
$312,406
|
$312,406
|
COPLAND, JOHN
|
MAYO CLINIC JACKSONVILLE
|
|
The NFkB-dependent Secretome and Invasion/Angiogenesis in Thyroid Cancer
|
1R01CA155512-01A1
|
$305,422
|
$305,422
|
HAUGEN, BRYAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Role of Skp2-cyclin A Interaction in Normal Physiology and Cancer
|
5R01CA131421-03
|
$300,705
|
$150,353
|
ZHU, LIANG
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
NIAID-REB research on Radiological & Nuclear threat activities
|
ZIA CP010185-10027
|
$294,986
|
$147,493
|
Simon, Steven
|
DCEG (NCI)
|
|
Childhood cancer survivor study (CCSS)
|
ZIA CP010131-04033
|
$290,720
|
$29,072
|
Inskip, Peter
|
DCEG (NCI)
|
|
Optical Biopsy Using Optical Coherence Tomography
|
5R01CA075289-15
|
$265,939
|
$53,188
|
FUJIMOTO, JAMES
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
Total relevant funding to Thyroid for this search: $16,207,259
|